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Case Report
Endovascular Therapy for a Patient With Chronic
Mesenteric Ischemia
Shin Rong Ke,1 Fu-Tien Chiang2*
Percutaneous transluminal angioplasty is now used widely in the revascularization of peripheral artery
disease. We report the case of a 75-year-old woman with chronic mesenteric ischemia, who presented
with postprandial abdominal pain, food fear, and weight loss for 6 months. Mesenteric angiography
showed critical stenosis in the celiac trunk, and superior and inferior mesenteric arteries. Instead of sur-
gical revascularization, balloon angioplasty and stenting was performed on the celiac trunk and supe-
rior mesenteric artery. The patient had improved appetite and weight gain after the procedure. This case
report demonstrates the clinical benefit of multiple vessel intervention with stenting in the treatment of
chronic mesenteric ischemia.
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Chronic mesenteric ischemia (CMI) is a rare but
catastrophic disease. Patients with this disease are
usually elderly and have multiple chronic diseases.
The symptoms of CMI include postprandial ab-
dominal pain, food fear, weight loss, nausea and
vomiting. If the mesenteric ischemia is not re-
lieved, the patient develops cachexia and acute
bowel ischemia, and death ensues.1 The treatment
of symptomatic CMI has traditionally involved
surgical procedures, which are associated with a
high technical success rate of up to 95%.2 Endo-
vascular therapy, including percutaneous translu-
minal angioplasty (PTA) and stenting, is now the
alternative choice for mesenteric revascularization.
Endovascular therapy has been reported to have
a lower peri-procedural complication rate and a
similar immediate technical success rate compared
with surgery. Here, we present a case of typical
CMI, whose symptoms were relieved completely
after PTA and stenting.
Case Report
A 75-year-old woman was admitted to the
National Taiwan University Hospital because of
epigastralgia and weight loss for 6 months. Her
past history was remarkable, with diabetes mellitus
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and hypertension controlled with oral medica-
tion. In addition, she had coronary artery disease
and had received coronary intervention four
times. The patient complained of intermittent ab-
dominal pain, especially at 10–15 minutes after
meals. The symptoms progressed and she became
afraid of eating. She lost 6 kg in weight within 6
months (from 60 to 54 kg). Laboratory examina-
tions (including liver function profiles) were
within normal ranges. The abdominal sonogra-
phy and endoscopy did not show abnormalities.
Under suspicion of mesenteric ischemia, mag-
netic resonance angiography was performed and
critical stenosis in the celiac trunk and inferior
mesenteric artery (IMA) was disclosed. She was
then admitted for mesenteric revascularization.
Angiography was performed via the right
femoral artery. Selective mesenteric angiography
showed 90% stenosis in the proximal portion of
the celiac trunk and 90% stenosis at the orifice 
of the IMA (Figures 1 and 2). The distal branches
of the celiac trunk could not be well opacified
because of critical stenosis. The superior mesen-
teric artery (SMA) could not be well studied as a
result of failed selective cannulation. In addition,
renal arteriography demonstrated irregular 80%
stenosis in the proximal portion of the right
renal artery and 50% stenosis in the left renal 
artery. Revascularization of the right renal artery
and celiac trunk was planned.
The right renal artery was cannulated with a
Renal double curve (Cordis/Johnson and Johnson,
Miami, FL, USA) 8F guiding catheter via the right
femoral artery. Direct stenting was performed
with a 6.0 × 18 mm Genesis stent (Cordis), with
good results. The same guiding catheter was used
to engage the celiac trunk, again with success, and
a 0.014 coronary wire was used to pass the le-
sion. We dilated the celiac ostial lesion with a 4.0×
20 mm coronary balloon and a suboptimal re-
sult was noted after the dilatation. A 4.0 × 16 mm
Liberté coronary stent (Boston Scientific Natick,
MA, USA) was deployed smoothly, which resulted
in around 20% residual steno-sis (Figure 3). The
post-procedural course was smooth. After dis-
charge, however, the postprandial abdominal
Figure 1. Critical stenosis in the celiac artery (arrow). The
hepatic artery (open arrow) was not observed.
Figure 2. Critical ostial stenosis in the inferior mesenteric
artery (arrow).
Figure 3. Angiogram of celiac artery after stenting (arrow).
The hepatic artery was well perfused (open arrow).
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pain only improved slightly. Further intervention
was planned 2 months after the first procedure.
Selective angiography of the mesenteric arteries
was performed again with a JR diagnostic catheter
(Medtronic, Minneapolis, MN, USA) through the
right femoral approach. There was 30% in-stent
restenosis in the celiac trunk, and 90% stenosis
in the ostium of the IMA. The SMA was opacified
successfully, and subocclusion was demonstrated
just distal to the middle colic artery (Figure 4).
We decided to use PTA on both the SMA and
IMA. A 7F PK1 guiding catheter (Metronic; 47 cm
long) was used to engage the SMA, and a 0.014
Rinato guide wire (Asahi Intec, Aichi, Japan) was
used to pass the lesion. The lesion was pre-dilated
with a 2.5 × 15 mm Maverick balloon and a 4.0 ×
12 mm Quantum balloon (Boston Scientific
Natick, MA, USA). A 6.0 × 18 mm Genesis stent
(Cordis) was deployed to the mid-portion of the
SMA, with good results (Figure 5). We used the
same PK1 guiding catheter and Rinato wire for
IMA intervention. The ostial lesion was dilated
with a 3.0 × 15 mm Sprinter coronary balloon
(Medtronic), 4.0×12 mm Quantum balloon, and
a 3.5 × 10 mm cutting balloon, but the balloons
could not be fully dilated. The final result showed
around 70% residual stenosis, with satisfactory
distal blood flow (Figure 6).
After the second intervention, the symptoms
improved dramatically. The patient gained 3 kg
in 2 months. The abdominal discomfort did not
recur for 4 months after the angioplasty.
Discussion
Atherosclerosis of the mesenteric arteries is not
rare in elderly. In an autopsy study of unselected
patients, splanchnic atherosclerosis was reported
in 35–70% patients.3 However, the incidence of
Figure 4. Angiogram of the superior mesenteric artery. The
distal superior mesenteric artery (arrow) was not opacified
because of the critical stenosis in the middle portion.
Figure 5. Angiogram of superior mesenteric artery after
stenting. The distal superior mesenteric artery was well
opacified (arrow).
Figure 6. Angiogram of inferior mesenteric artery after
balloon dilatation (arrow).
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CMI is low in clinical practice. Patients with
mesenteric artery disease may be symptom free
until the blood supply cannot meet the postpran-
dial demand. There are three visceral vessels that
supply the bowel: the celiac trunk, SMA, and IMA.
Between these, there are abundant collateral ves-
sels. Clinical symptoms usually are caused by
stenosis or occlusion of multiple mesenteric ar-
teries. The symptoms of CMI are nonspecific and
the physical findings are not remarkable, there-
fore, the diagnosis is difficult and a high degree
of clinical suspicion is needed. In addition, CMI
is a progressive disease. Patients with significant
three-vessel disease have been followed in a pre-
vious study, and 86% of the asymptomic pa-
tients had incident intestinal ischemia.1 In some
patients, acute intestinal ischemia and death even-
tually develop. Therefore, correct diagnosis and
treatment of CMI are important. Diagnosis of CMI
traditionally has been achieved by catheter angiog-
raphy, but computed tomography angiography
and magnetic resonance angiography are associ-
ated with high diagnostic sensitivity and specificity.
Catheter angiography is now recommended when
endovascular therapy is planned.
Open surgical revascularization is the tradi-
tional therapy for CMI. There are several different
surgical approaches, which can be divided into
two categories: endarterectomy and vascular by-
pass. The overall technical success rate is around
95%, and the 5-year survival rate is reported as
61–64%. The overall 5-year graft patency is around
78%. However, the perioperative complication
rate is reported to be between 33% and 47%,
and the 30-day mortality rate is around 10%.2 In
patients with multiple underlying diseases, the
operation carries high mortality and morbidity.
Endovascular therapy is a less invasive technique
and has become an attractive alternative option.
Endovascular revascularization has been used
for different peripheral artery diseases, including
those of the renal and iliac arteries. For mesenteric
artery stenosis, the first successful angioplasty
was reported in 1980 by Furrer et al.4 In several
small series, endovascular therapy has been re-
ported to have a technical success rate of 90%.5,6
Compared with surgical therapy, PTA has poten-
tial advantages such as shorter hospital stay, less
invasiveness, a lower cost, and fewer major com-
plications. Although mesenteric PTA is considered
to be an effective and safe choice, comparative
studies of surgery and PTA have been rare. In a
retrospective study that compared endovascular
and open revascularization, the immediate tech-
nical success rate was similar in the two groups
(95.3% in the PTA and 100% in the surgical
group). However, freedom from symptoms was
greater in the open group (68% and 59% for 
1 and 2 years in the open group, and 27% and
20% in the endovascular group).7 In conclusion,
endovascular therapy was considered as a less
durable treatment. There were two possible rea-
sons that favored surgery. First, there were more
vessels that were treated by surgery. Anatomically,
the mesenteric arteries arise from the ventral 
surface of the abdominal aorta, at a sharp angle,
and good catheter engagement with the arteries
is not always possible. The anatomical difficulty
with PTA could result in incomplete revascu-
larization. Second, some patients received bal-
loon angioplasty without stenting in mesenteric
PTA. Peripheral stenting has proved effective in
the revascularization of renal and iliac artery dis-
ease.8,9 Stent deployment can overcome acute
closure and vascular recoil, and reduce the rate
of late restenosis. Open and endovascular proce-
dures for mesenteric revascularization might have
different results in the stent era. In one study of
mesenteric PTA with stenting, the procedural
success was 96% and the symptom relief rate was
88%.10 After 5-year follow-up, the symptom-free
and survival rates were 72% and 79%, respectively,
which is comparable to previous surgical studies.
In patients with multiple vessel intervention, there
was less symptom recurrence. In our patient, we
performed successful PTA and stenting of two
vessels: the celiac artery and SMA. We expected a
long-term benefit comparable with that of surgery.
In conclusion, we describe a patient with CMI
that was diagnosed with magnetic resonance an-
giography and treated with endovascular therapy.
The symptoms of CMI improved partially after the
Endovascular therapy for mesenteric ischemia
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first intervention, and the discomfort was relieved
completely after the secondary procedure. When
endovascular therapy is performed in patients with
CMI, we suggest multiple vessel intervention and
stent deployment.
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